KMID : 0390220180290010087
|
|
Journal of Clinical Otolaryngology, Head and Neck Surgery 2018 Volume.29 No. 1 p.87 ~ p.90
|
|
Sudden Sensorineural Hearing Loss after Granulocyte-Colony Stimulating Factor Administration
|
|
Kim Seon-Lin
Oh Se-Joon Kong Soo-Keun Goh Eui-Kyung
|
|
Abstract
|
|
|
Filgrastim¨Þ (Granulocyte-colony stimulating factor, G-CSF) is generally used to promote the increase of neutrophils to patients with neutropenia during chemotherapy or donors for hematopoietic stem cell transplantation (HSCT). Its adverse effects were mainly reported as non-serious symptoms, such as back pain, headache, arthralgia and fever. A 29-year-old male was administered the Filgrastim as a HSCT donor. He accompanied left side hearing disturbance and tinnitus after 2 days from administration of the drug. He admitted to our department and underwent improvement of hearing after high dose steroid therapy. In this report, we describe a case of sudden sensorineural hearing loss (SSNHL) as an unreported adverse effect of G-CSF in the literature.
|
|
KEYWORD
|
|
Filgrastim, Neutrophil-to-lymphocyte ratio, Sudden sensorineural hearing loss, Granulocyte-colony stimulating factor
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|